Business Context and Reporting Period
This Form 8-K was filed by NorthView Acquisition Corp. in connection with its proposed business combination with Infrared Cameras Holdings, Inc., referred to as Profusa. The report concerns events occurring January 12, 2024, although the signature is dated January 19, 2024.
Under the merger agreement, NorthView’s wholly owned subsidiary would merge with Profusa, with Profusa surviving as a wholly owned subsidiary. NorthView is expected to be renamed Profusa, Inc. The filing is also designated as written communications under Rule 425 and relates to the proposed transaction.
Key Financial Metrics and Liquidity
The filing does not provide current-period revenue, profit or loss, cash flow, margins, debt, liquidity, balance-sheet data or other operating financial metrics.
The filing references an amended earnout milestone that had required $11,864,000 of revenue for the fiscal year ending December 31, 2024. That revenue milestone was replaced with a requirement to consummate the contemplated Tasly joint venture and receive related funding during fiscal 2024.
Material Changes Versus the Prior Comparable Period
- On January 12, 2024, NorthView, Profusa and Merger Sub entered into Amendment No. 2 to the merger agreement.
- The definition of “Milestone Event III” was revised.
- The $11,864,000 fiscal 2024 earnout revenue milestone was replaced by the Tasly joint venture and related funding milestone.
- The outside date for consummating the business combination was extended from September 21, 2023, to June 22, 2024. After that date, the merger agreement may be terminable by Profusa or NorthView, subject to the agreement’s terms.
Guidance, Outlook, Risks and Unusual Items
The filing does not provide formal financial guidance. It describes anticipated benefits of the proposed transaction, potential public-company status for the combined business, Profusa’s product and service offerings, and the planned Tasly joint venture, but these statements are forward-looking and not assured.
- Completion remains subject to NorthView stockholder approval and satisfaction of other closing conditions.
- The transaction may be terminated under specified circumstances, including failure to close by the applicable outside date.
- Redemption requests by NorthView public stockholders could affect transaction funding and the capitalization of the combined company.
- Other risks include transaction costs, potential litigation or regulatory proceedings, disruption to operations, the ability to realize expected benefits, customer acceptance of Profusa’s offerings and the impact of broader economic or public-health conditions.
- The filing states that the proxy statement/prospectus and related SEC filings should be reviewed before making voting or investment decisions.
Important Facts for Investors to Verify
- Whether the definitive proxy statement/prospectus has been filed and declared effective, and whether NorthView stockholders approve the transaction.
- Whether all merger closing conditions are satisfied before June 22, 2024, or whether the outside date is further amended.
- Whether the Tasly joint venture is consummated and related funding is received during fiscal 2024.
- The amount of public-stockholder redemptions and the resulting cash available to the combined company.
- Profusa’s audited financial statements, cash runway, debt, operating losses, revenue history and other financial information in the merger materials.